Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Phase III Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection for Colon Cancer: An Intergroup Trial of the ECOG-ACRIN Cancer Research Group (E1292).

Autor: Kemeny MM; Icahn School of Medicine at Mount Sinai, Queens Cancer Center of NYC Health + Hospitals/Queens, Jamaica, NY, USA. kemenym@nychhc.org., Zhao F; Dana Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, MA, USA., Forastiere AA; John Hopkins University and Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA., Catalano P; Dana Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, MA, USA., Hamilton SR; MD Anderson Cancer Center, Houston, TX, USA., Miedema BW; University of Missouri-Ellis Fischel, Columbia, MO, USA., Dawson NA; Lombardi Comprehensive Cancer Center, Washington, DC, USA., Weiner LM; Lombardi Comprehensive Cancer Center, Washington, DC, USA., Smith BD; Wilmont Cancer Center, Rochester, NY, USA., Mason BA; Pennsylvania Hospital, Philadelphia, PA, USA., Graziano SL; State University of New York Upstate Medical University, Syracuse, NY, USA., Gilman PB; Lankenau Medical Center, Wynnewood, PA, USA., Venook AP; Helen Diller Family Comprehensive Cancer Center, USCF, San Francisco, CA, USA., Pinto HA; Stanford Cancer Institute, Palo Alto, CA, USA., Whitehead RP; Nevada Cancer Institute, Las Vegas, NV, USA., O'Dwyer PJ; University of Pennsylvania and Abramson Cancer Center, Philadelphia, PA, USA., Benson AB; Northwestern University, Chicago, IL, USA.

Publikováno v: Annals of surgical oncology [Ann Surg Oncol] 2023 Feb; Vol. 30 (2), pp. 1099-1109. Date of Electronic Publication: 2022 Oct 28.

A Coala-T-Cannabis Survey Study of breast cancer patients' use of cannabis before, during, and after treatment.

Autor: Weiss MC; Breastcancer.org, Ardmore, Pennsylvania.; Socanna, Narberth, Pennsylvania.; Radiation Oncology, Lankenau Medical Center, Wynnewood, Pennsylvania.; Lankenau Institute for Medical Research, Wynnewood, Pennsylvania., Hibbs JE; Medical Oncology, Lankenau Medical Center, Wynnewood, Pennsylvania., Buckley ME; Center for Population Health Research, Main Line Health, Wynnewood, Pennsylvania., Danese SR; Outcomes Insights, Agoura Hills, California., Leitenberger A; Breastcancer.org, Ardmore, Pennsylvania., Bollmann-Jenkins M; Breastcancer.org, Ardmore, Pennsylvania., Meske SW; Lankenau Institute for Medical Research, Wynnewood, Pennsylvania.; Center for Population Health Research, Main Line Health, Wynnewood, Pennsylvania., Aliano-Ruiz KE; Lankenau Institute for Medical Research, Wynnewood, Pennsylvania., McHugh TW; Medical Oncology, Lankenau Medical Center, Wynnewood, Pennsylvania., Larson SL; Center for Population Health Research, Main Line Health, Wynnewood, Pennsylvania., Le EH; Healthline, San Francisco, California., Green NL; Donovan/Green, New York, New York., Gilman PB; Lankenau Institute for Medical Research, Wynnewood, Pennsylvania., Kaklamani VG; Medical Oncology, Internal Medicine, University of Texas Health San Antonio, San Antonio, Texas., Chlebowski RT; Lundquist Institute for Biomedical Innovation, Harbor-UCLA Medical Center, Torrance, California., Martinez DM; Department of Psychiatry, Columbia University Irving Medical Center, New York, New York.

Publikováno v: Cancer [Cancer] 2022 Jan 01; Vol. 128 (1), pp. 160-168. Date of Electronic Publication: 2021 Oct 12.

Preliminary evaluation of a predictive blood assay to identify patients at high risk of chemotherapy-induced nausea.

Autor: Kutner T; Lankenau Institute for Medical Research, Lankenau Medical Center, Wynnewood, PA, 19096, USA., Kunkel E; Lankenau Institute for Medical Research, Lankenau Medical Center, Wynnewood, PA, 19096, USA., Wang Y; Hematology/Oncology Fellowship Program, Lankenau Medical Center, Wynnewood, PA, 19096, USA., George K; Lankenau Institute for Medical Research, Lankenau Medical Center, Wynnewood, PA, 19096, USA., Zeger EL; Lankenau Institute for Medical Research, Lankenau Medical Center, Wynnewood, PA, 19096, USA.; Department of Medical Oncology, Lankenau Medical Center, Wynnewood, PA, 19096, USA., Ali ZA; Lankenau Institute for Medical Research, Lankenau Medical Center, Wynnewood, PA, 19096, USA.; Department of Medical Oncology, Lankenau Medical Center, Wynnewood, PA, 19096, USA., Prendergast GC; Lankenau Institute for Medical Research, Lankenau Medical Center, Wynnewood, PA, 19096, USA., Gilman PB; Lankenau Institute for Medical Research, Lankenau Medical Center, Wynnewood, PA, 19096, USA.; Department of Medical Oncology, Lankenau Medical Center, Wynnewood, PA, 19096, USA., Wallon UM; Lankenau Institute for Medical Research, Lankenau Medical Center, Wynnewood, PA, 19096, USA. wallon@limr.org.

Publikováno v: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2017 Feb; Vol. 25 (2), pp. 581-587. Date of Electronic Publication: 2016 Oct 12.

The symptom burden of cancer: Evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study.

Autor: Cleeland CS; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas., Zhao F, Chang VT, Sloan JA, O'Mara AM, Gilman PB, Weiss M, Mendoza TR, Lee JW, Fisch MJ

Publikováno v: Cancer [Cancer] 2013 Dec 15; Vol. 119 (24), pp. 4333-40. Date of Electronic Publication: 2013 Sep 24.